Study guide

10.1 Acute Poisoning & Toxidromes

MRCPI in General Medicine Part I Written

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Strategy & Foundation

1.1 MRCPI Part I Format, Scoring & Standard-Setting 1.2 RCPI BST Curriculum & Single-Best-Answer Exam Strategy

2 Chapter 2: Cardiology & Vascular Medicine

2.1 Acute Coronary Syndromes & Stable Angina 2.2 Tachyarrhythmias, Bradyarrhythmias & Channelopathies 2.3 Heart Failure & Valvular Heart Disease 2.4 Hypertension, Vascular & Pericardial Diseases

3 Chapter 3: Respiratory Medicine

3.1 Asthma, COPD & Airway Diseases 3.2 Pneumonia, Tuberculosis & Respiratory Infections 3.3 Interstitial Lung Disease & Pleural Disorders 3.4 Pulmonary Embolism, Pulmonary Hypertension & Sleep Apnoea

4 Chapter 4: Gastroenterology & Hepatology

4.1 Upper & Lower GI Disorders & Inflammatory Bowel Disease 4.2 Acute & Chronic Liver Disease 4.3 Pancreatitis, Biliary Tract & GI Bleeding 4.4 Malabsorption, GI Motility & Clinical Nutrition

5 Chapter 5: Nephrology & Acid-Base Disorders

5.1 Acute Kidney Injury & Glomerular Diseases 5.2 Chronic Kidney Disease & Renal Replacement Therapy 5.3 Electrolyte Imbalances & Acid-Base Disorders

6 Chapter 6: Endocrinology & Diabetes

6.1 Diabetes Mellitus & Metabolic Complications 6.2 Thyroid & Calcium Disorders 6.3 Adrenal, Pituitary & Endocrine Syndromes

7 Chapter 7: Rheumatology & Clinical Immunology

7.1 Inflammatory Arthritides 7.2 Systemic Autoimmune & Vasculitic Diseases 7.3 Metabolic Bone Disease & Clinical Immunology

8 Chapter 8: Haematology & Medical Oncology

8.1 Anaemias, Haemostasis & Thrombosis 8.2 Leukaemias, Lymphomas & Plasma Cell Disorders 8.3 Medical Oncology & Oncological Emergencies

9 Chapter 9: Neurology & Dermatology

9.1 Stroke & Cerebrovascular Diseases 9.2 Epilepsy, Headache & Movement Disorders 9.3 Neuromuscular & Peripheral Nerve Disorders 9.4 Cutaneous Manifestations of Systemic Disease

10 Chapter 10: Acute Medicine, Critical Care & Geriatrics

10.1 Acute Poisoning & Toxidromes 10.2 Sepsis, Shock & Resuscitation 10.3 Geriatric Syndromes, Frailty & Comprehensive Care

11 Chapter 11: Clinical Pharmacology & Therapeutics

11.1 Pharmacokinetics & Pharmacodynamics 11.2 High-Risk Drug Classes & Prescribing Safety 11.3 Adverse Drug Reactions & Drug Safety

12 Chapter 12: Basic Sciences, Biostatistics & Clinical Ethics

12.1 Applied Cardiovascular & Respiratory Physiology 12.2 Clinical Biochemistry, Molecular Genetics & Microbiology 12.3 Biostatistics, Evidence-Based Medicine & Ethics

10.1 Acute Poisoning & Toxidromes

Key Takeaways Explain This Topic AI

Paracetamol (acetaminophen) hepatotoxicity is driven by N-acetyl-p-benzoquinone imine (NAPQI) accumulation when glutathione stores fall below 30%; N-acetylcysteine (NAC) is virtually 100% protective against severe liver injury if administered within 8 hours of ingestion.

The King's College Hospital Criteria for paracetamol-induced acute liver failure indicate emergency liver transplantation referral if arterial pH < 7.30 after fluid resuscitation OR if all three of prothrombin time > 100 seconds (INR > 6.5), serum creatinine > 300 µmol/L, and grade III/IV hepatic encephalopathy are present.

Salicylate toxicity produces a mixed respiratory alkalosis (direct respiratory center stimulation) and severe metabolic acidosis (uncoupling of oxidative phosphorylation); urinary alkalinisation with intravenous sodium bicarbonate to achieve a urine pH of 7.50–7.55 enhances renal clearance.

Toxidrome recognition allows rapid syndromic identification prior to laboratory confirmation: anticholinergic ("mad as a hatter, blind as a bat"), cholinergic ("SLUDGEM"), opioid (miosis, respiratory depression, coma), and sympathomimetic (hyperthermia, mydriasis, diaphoresis).

Last updated: July 2026

  • 10.1 Acute Poisoning & Toxidromes
  • General Principles & Emergency Decontamination

The initial approach to acute poisoning in adult medicine requires immediate clinical stabilization adhering to structured Resuscitation A-B-C-D-E principles before pursuing toxin identification. Protecting the airway is paramount, particularly in obtunded patients with a Glasgow Coma Scale (GCS) score ≤ 8 \le 8 ≤ 8 or those who have ingested central nervous system (CNS) depressants, hydrocarbon solvents, or corrosive agents. Early consultation with national poisons information services (such as TOXBASE in the UK and Ireland) provides authoritative, evidence-based guidance regarding toxic doses, kinetic profiles, and specific antidote protocols.

Decontamination strategies must be applied judiciously. Single-dose activated charcoal ( 1 g/kg 1\text{ g/kg} 1 g/kg up to 50 g 50\text{ g} 50 g ) adsorbs many small organic molecules but is clinically beneficial only when administered within 1 hour of ingesting an adsorbable substance. Charcoal is ineffective for heavy metals (lead, iron, lithium), alcohols (ethanol, ethylene glycol, methanol), corrosive acids/alkalis, cyanides, and essential ions (potassium, sodium). Gastric lavage and syrup of ipecac are obsolete in contemporary toxicology due to significant risks of pulmonary aspiration, oesophageal perforation, and lack of proven clinical benefit. Whole bowel irrigation using polyethylene glycol solution ( 1 − 2 L/hour 1-2\text{ L/hour} 1 − 2 L/hour ) is reserved for sustained-release preparations, massive iron overdoses, or body packers carrying illicit drug packets.

Recognition of Classic Toxidromes

A toxidrome is a constellation of clinical signs and symptoms characteristic of a specific class of toxin. Rapid recognition allows syndromic diagnosis and empirical treatment prior to receiving laboratory blood toxicological screens.

Toxidrome Mental Status Pupil Size Vital Signs Skin & Secretions Classic Etiologies

Anticholinergic Delirium, agitation, hallucinations Mydriasis (dilated) Tachycardia, hyperthermia, hypertension Dry, flushed skin, dry mucous membranes Atropine, diphenhydramine, hyoscine, tricyclic antidepressants

Cholinergic Confusion, coma, seizures Miosis (constricted) Bradycardia, hypotension, tachypnoea Diaphoresis, lacrimation, salivation, bronchorrhoea (SLUDGEM) Organophosphate insecticides, nerve agents, carbamates

Sympathomimetic Agitation, paranoia, hyperalertness Mydriasis (dilated) Tachycardia, severe hypertension, hyperthermia Diaphoresis (profuse sweating), piloerection Cocaine, amphetamines, MDMA, methamphetamine, ephedrine

Opioid CNS depression, coma Miosis (pinpoint) Hypoventilation/bradypnoea, bradycardia, hypotension Normal or cool skin, hypothermia Morphine, methadone, oxycodone, fentanyl, heroin

Sedative-Hypnotic Stupor, coma, ataxia Normal or variable Hypoventilation, hypotension, bradycardia Dry skin, hypothermia Benzodiazepines, z-drugs, barbiturates, ethanol

Clinical Exam Pearl: The physical examination of the skin reliably differentiates sympathomimetic from anticholinergic toxidromes. Patients with sympathomimetic toxicity present with profuse diaphoresis ("soaking wet"), whereas anticholinergic toxicity produces dry axillae and anhidrotic, warm skin ("dry as a bone").

Paracetamol Toxicity & Acute Liver Failure

Paracetamol (acetaminophen) is the most common agent involved in deliberate self-poisoning. Toxic doses ( > 75 − 150 mg/kg > 75-150\text{ mg/kg} > 75 − 150 mg/kg or > 12 g > 12\text{ g} > 12 g in an adult) saturate hepatic phase II glucuronidation and sulfation pathways. Excess drug is shunted to Cytochrome P450 ( CYP2E1 ), generating N-acetyl-p-benzoquinone imine (NAPQI) , a highly reactive toxic metabolite. When hepatic glutathione reserves fall below 30% , NAPQI covalently binds to hepatocyte proteins, inducing acute centrilobular hepatic necrosis.

Timing of Paracetamol Levels & Nomogram Interpretation

< 4 < 4 < 4 Hours Post-Ingestion: Serum levels are uninterpretable due to incomplete absorption. Administer activated charcoal if within 1 hour.

4 − 8 4-8 4 − 8 Hours Post-Ingestion: Measure serum paracetamol concentration at exactly 4 hours. Compare against the single treatment line ( 100 mg/L 100\text{ mg/L} 100 mg/L at 4 hours, declining to 15 mg/L 15\text{ mg/L} 15 mg/L at 15 hours). If above the line, commence N-acetylcysteine (NAC) immediately.

> 8 > 8 > 8 Hours Post-Ingestion: Start NAC infusion immediately without waiting for lab results. Discontinue later if the level falls below the treatment line and LFTs/INR are normal.

NAC restores hepatic glutathione stores. When administered within 8 hours of acute ingestion, NAC provides near 100 % 100\% 100% protection against severe hepatotoxicity. Modern practice utilizes a simplified 2-bag infusion protocol ( 150 mg/kg 150\text{ mg/kg} 150 mg/kg over 2 hours, followed by 200 mg/kg 200\text{ mg/kg} 200 mg/kg over 10 hours) to reduce anaphylactoid adverse reactions (flushing, pruritus, bronchospasm). If an anaphylactoid reaction occurs, temporarily pause the infusion, administer chlorphenamine, and resume NAC at a reduced rate once symptoms resolve.

King's College Hospital Criteria for Acute Liver Failure

Patients developing severe liver injury require urgent discussion with a liver transplant unit.

Category Criteria for Emergency Liver Transplantation

Paracetamol-Induced ALF Arterial pH < 7.30 < 7.30 < 7.30 (or lactate > 3.0 mmol/L > 3.0\text{ mmol/L} > 3.0 mmol/L ) after fluid resuscitation,; OR all three of the following within 24 hours:; 1. Prothrombin time > 100 seconds > 100\text{ seconds} > 100 seconds (INR > 6.5 > 6.5 > 6.5 ); 2. Serum creatinine > 300 μ mol/L > 300\text{ }\mu\text{mol/L} > 300 μ mol/L ( > 3.4 mg/dL > 3.4\text{ mg/dL} > 3.4 mg/dL ); 3. Grade III or IV hepatic encephalopathy

Non-Paracetamol ALF Prothrombin time > 100 seconds > 100\text{ seconds} > 100 seconds (INR > 6.5 > 6.5 > 6.5 ),; OR any three of the following five parameters:; 1. Age < 10 < 10 < 10 or > 40 > 40 > 40 years; 2. Etiology: non-A/non-B hepatitis, halothane, idiosyncratic drug reaction; 3. Duration of jaundice before encephalopathy > 7 days > 7\text{ days} > 7 days ; 4. Prothrombin time > 50 seconds > 50\text{ seconds} > 50 seconds (INR > 3.5 > 3.5 > 3.5 ); 5. Serum bilirubin > 300 μ mol/L > 300\text{ }\mu\text{mol/L} > 300 μ mol/L

  • Salicylate & Tricyclic Antidepressant Overdose
  • Salicylate Toxicity (Aspirin)

Salicylates directly stimulate the medullary respiratory center, causing hyperventilation and respiratory alkalosis . Concurrently, salicylates uncouple oxidative phosphorylation, inhibiting the Krebs cycle and accumulating lactate, pyruvate, and acetoacetate, generating a severe high anion gap metabolic acidosis . Clinical features include tinnitus, vertigo, vomiting, hyperpyrexia, sweating, and confusion.

Management involves aggressive resuscitation, correction of hypokalaemia, and urinary alkalinisation . Infusing 1.26 % 1.26\% 1.26% or 8.4 % 8.4\% 8.4% sodium bicarbonate to achieve a urine pH of 7.50 − 7.55 7.50-7.55 7.50 − 7.55 ion-traps salicylate ( Salicylate − \text{Salicylate}^- Salicylate − ) in the renal tubules, accelerating urinary elimination. Extracorporeal haemodialysis is indicated for serum salicylate levels > 500 mg/L > 500\text{ mg/L} > 500 mg/L ( 3.6 mmol/L 3.6\text{ mmol/L} 3.6 mmol/L ) in acute overdose, severe metabolic acidosis ( pH < 7.20 \text{pH} < 7.20 pH < 7.20 ), acute kidney injury, pulmonary oedema, or central nervous system impairment.

Tricyclic Antidepressant (TCA) Overdose

TCAs (amitriptyline, dosulepin) induce toxicity via four mechanisms: central anticholinergic blockade, peripheral alpha-1 adrenergic blockade (hypotension), cardiac fast sodium channel blockade (QRS prolongation), and inhibition of reuptake of monoamines. ECG changes dictate mortality risk:

QRS duration > 120 ms > 120\text{ ms} > 120 ms : Predicts increased risk of seizures.

QRS duration > 160 ms > 160\text{ ms} > 160 ms : Predicts high risk of ventricular arrhythmias (ventricular tachycardia/fibrillation).

Terminal 40 ms 40\text{ ms} 40 ms QRS axis shift: Prominent R wave in lead aVR ( > 3 mm > 3\text{ mm} > 3 mm ).

First-line therapy for TCA-induced cardiac toxicity (QRS widening or hypotension) is intravenous sodium bicarbonate 8.4% ( 1 − 2 mmol/kg 1-2\text{ mmol/kg} 1 − 2 mmol/kg boluses). Sodium bicarbonate increases extracellular sodium concentration to compete with fast sodium channel blockade and induces serum alkalinisation ( target pH 7.45 − 7.55 \text{target pH } 7.45-7.55 target pH 7.45 − 7.55 ), which increases protein binding of the drug and decreases the active free serum concentration. Antiarrhythmics such as amiodarone, procainamide, and flecainide are strictly contraindicated.

Antidote Summary & Enhanced Elimination

Specific antidotes play vital roles in critical toxicological resuscitation:

  • Poison / Drug Class Specific Antidote / Specific Agent Clinical Mechanism of Action
  • Opioids Naloxone Competitive opioid receptor antagonist ( 0.4 − 2.0 mg 0.4-2.0\text{ mg} 0.4 − 2.0 mg IV/IM)

Organophosphates Atropine + Pralidoxime Atropine blocks muscarinic receptors; pralidoxime reactivates acetylcholinesterase

Toxic Alcohols (Methanol / Ethylene Glycol) Fomepizole (or Ethanol) Competitive inhibitor of alcohol dehydrogenase (ADH), preventing toxic acid production

Digoxin Digoxin-specific Fab antibodies Binds free serum digoxin, reversing Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -ATPase pump inhibition

Beta-blockers / Calcium Channel Blockers High-dose Insulin Euglycaemic Therapy (HIET) + Calcium Chloride HIET ( 1 unit/kg 1\text{ unit/kg} 1 unit/kg bolus + 1 unit/kg/hr 1\text{ unit/kg/hr} 1 unit/kg/hr ) provides ionotropic energy substrate to myocytes

Local Anaesthetic Toxicity (LAST) Intravenous Lipid Emulsion (Intralipid 20%) Acts as a "lipid sink" extracting lipophilic local anaesthetics from target cardiac/brain tissue

Haemodialysis effectively removes toxins characterized by low molecular weight ( < 500 Da < 500\text{ Da} < 500 Da ), low volume of distribution ( < 1 L/kg < 1\text{ L/kg} < 1 L/kg ), low plasma protein binding, and high water solubility. The toxicological mnemonic VISTAA outlines classic dialyzable toxins: V alproate, I sopropanol, S alicylates, T heophylline, A lcohol/Methanol/Ethylene glycol, and L ithium.